TrialKey

Our time at BIO Asia–Taiwan has been incredibly productive! Thanks to Australian Trade and Investment Commission (Austrade) for organising the largest-ever Australian Pavilion. This platform allowed us to promote our biotech capabilities and explore commercial partnerships with Taiwanese companies. Bernice Averion, Head of Marketing & Communications, and Minh-Thu Cao Xuan, Business Development Manager, have been showcasing TrialKey’s AI-driven solutions, including our database of over 350,000 clinical trial insights and predictions, and our TrialGen Clinical Trial Design Simulator. Marketing & Opyl investor enquiries: bernice.averion@opyl.ai Sales: minhthu.caoxuan@opyl.ai #bioasiataiwan #opyl #trialkey #clinicaltrials #drugdiscovery #ai #austrade #biotech #precisionmedicine #clinicalresearch

Enhance your clinical trial proposals with TrialKey! We've been demoing TrialGen to attendees at Bio Asia-Taiwan, showcasing its transformative capabilities. Discover how TrialKey can revolutionize your clinical trials. TrialKey is an advanced AI-driven platform designed for precise clinical trial design and execution. TrialKey's TrialGen leverages insights from over 350,000 trials across 700+ variables, utilising real-world data to optimize trial design, improve resource allocation, and significantly increase trial success rates. Visit us at the Australian Pavilion to meet Bernice Averion and Minh-Thu Cao Xuan for a live demo of TrialKey. Book a demo via https://appt.link/minhthu Marketing and Opyl enquiries: bernice@trialkey.ai #clinicaltrials #clinicalresearch #medicalresearch #biotech #taiwan #medtech #drugdiscovery #healthcareinnovation #pharmaresearch #lifesciences #researchanddevelopment #biomedicalresearch #BioAsiaTaiwan

We're excited to be a participating exhibitor at BIO Asia–Taiwan thanks to Australian Trade and Investment Commission (Austrade)! TrialKey (ASX: OPL) is a game-changer for accelerating clinical research and Ai-driven trial design optimisation, capable of simulating any trial in any phase, including medical devices, alternative therapies, and non-randomised drug control trials. The Australia-Taiwan Health and Biotechnology Partnership, established in May 2023, provides a framework for collaboration in clinical trials and biotech innovation. TrialKey.ai's global applicability and advanced capabilities will be instrumental in supporting worldwide medical community's goals, enhancing trial success rates, and reducing costs through data-driven optimisation. Come meet the Head of Marketing & Communications Bernice Averion and Business Development Manager Minh-Thu Cao Xuan for a live demo of TrialKey. Alternatively, book a virtual demo via https://lnkd.in/g9rJtUBm Marketing and Opyl investor enquiries: bernice.averion@opyl.ai #clinicaltrials #clinicalresearch #medicalresearch #biotech #taiwan #medtech #drugdiscovery #healthcareinnovation #pharmaresearch #lifesciences #researchanddevelopment #biomedicalresearch #opyl #trialkey #asx #biotechinvestment #biotechnology

Thrilled to announce a strategic MOU between Opyl with the Xco consortium, led by Whit Pepper and Dr Greg Bailey, marking the start of a joint venture to market and sell TrialKey’s products in Europe, the Middle East, Africa, and North America. This collaboration will undergo a three-month due diligence period to finalise all terms. The partnership includes a USD 1 million cash payment, a 20% equity stake in the JV, revenue sharing, and ambitious sales targets: USD 1 million in the first year, USD 2 million in the second, and USD 4 million in the third. Whit and Dr Bailey bring invaluable expertise and experience, making this a significant step towards global expansion and enhanced stakeholder value. For investor and marketing enquiries: bernice@trialkey.ai. Book a TrialKey demo: https://lnkd.in/g9rJtUBm #clinicaltrials #medicalinnovation #drugdevelopment #biotechnology #medtechnews #investmentopportunities #asxnews #pharma #saas #medicalresearch

One week left until TrialKey (ASX: OPL)is at BIO Asia–Taiwan! Join us at the Australian Pavilion, one of the largest platforms for showcasing Australian clinical trials and biotech capabilities. Meet our Head of Marketing & Communications, Bernice Averion, and Business Development Manager, Minh-Thu Cao Xuan, for a live demo of TrialKey. Book an in person demo for July 24-27 through https://lnkd.in/gf7HNmq7 #trialkey #opyl #bioasiataiwan #bioasia2024 #clinicaltrials #medicalresearch #pharma #biotech #clinicalresearch #aiinmedicine

Clinical research is crucial for advancing medical knowledge and improving patient outcomes, yet over-recruiting patients remains a significant challenge. This leads to inflated costs and inefficient resource use. A TrialKey.ai analysis of a Focal Segmental Glomerulosclerosis (FSGS) study recommended enrolling 200 participants instead of 286. This optimised number increased the trial’s success likelihood by 28% and would've resulted in significant cost savings. The original cost of enrolling 286 participants was approximately $11,615,032, while enrolling 200 participants would have saved $3,492,632, reducing the total cost to $8,122,400. By leveraging TrialKey.ai's advanced algorithms and real-world evidence, researchers can achieve optimal participant numbers, mitigate overspending, and enhance trial success rates. Keen to learn more about a particular trial? Book a demo today and let us know an NCT you're interested in https://lnkd.in/g9rJtUBm Read more here: https://lnkd.in/g2iDE2uj #trialkey #opyl #patientenrollment #clinicaltrials 

Discover how AI is revolutionising the clinical trial industry with Saurabh Jain on the AI Advantage Show, hosted by Richard Wray! Learn about TrialGen, TrialKey's AI-driven Clinical Trial Simulator, which predicts trial success with 90% accuracy using real-world data. Understand the critical role of AI in optimising trial design, patient recruitment, and phase predictions, setting new ethical standards in clinical research. Listen now: https://lnkd.in/gCXN8SJ7 Book a demo:https://lnkd.in/g9rJtUBm Marketing and investor enquiries: bernice.averion@opyl.ai #clinicaltrials #ai #medicalresearch #trialkey #drugdiscovery #healthtech #biotech #aitechnology

Saurabh Jain, Executive Chairman of Opyl and TrialKey, shared his insights on the 'Inspired by Success | Podcast' hosted by Linda Vo. The episode, "AI in Healthcare: How It's Revolutionizing Clinical Trials," covers the profound impact of AI on healthcare, particularly in clinical trials. Listen now: https://lnkd.in/g9rJtUBm Saurabh emphasizes the value of hard work, continuous learning, and being coachable as key entrepreneurial traits. He also discusses the importance of allocating capital effectively to achieve successful trials. Learn how sustainable systems and strong teams are critical for leadership and long-term success in the biotech industry.  Marketing, investor and speaking enquiries: bernice.averion@opyl.ai Book a demo: https://lnkd.in/g9rJtUBm #clinicaltrials #medicalinnovation #healthcareai #biotechnology #clinicaldesign #aihealthcare #medtech #digitalhealth #asx #biotech #ai